Receptor activator of nuclear factor B ligand (RANKL): another link between breast and bone

By Martin T.J.   Gillespie M.T.  

Trends in Endocrinology and Metabolism, Vol. 12, Iss. 1, 2001-01 ,pp. : 2-4

Elsevier

Access to resources Recommend Favorite

Expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression

By Schubert Antje   Schulz Hiltrud   Emons Gunter   Grundker Carsten  

Gynecological Endocrinology, Vol. 24, Iss. 6, 2008-01 ,pp. : 331-338

Informa Healthcare

Access to resources Recommend Favorite

Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis

By Rendina D.   De Filippo G.   Viceconti R.   Soscia E.   Sirignano C.   Salvatore M.   Della Monica M.   Scarano G.   Mossetti G.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 3, 2008-01 ,pp. : 225-229

Informa Healthcare

Access to resources Recommend Favorite

Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation

By Chen Chun-Hsiung   Chen Hung-An   Liao Hsien-Tzung   Liu Chin-Hsiu   Tsai Chang-Youh   Chou Chung-Tei  

Clinical Rheumatology, Vol. 29, Iss. 10, 2010-10 ,pp. : 1155-1161

Springer Publishing Company

Access to resources Recommend Favorite

Minodronic acid influences receptor activator of nuclear factor kB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis

By Tanishima Shinji   Kishimoto Yuji   Fukata Satoru   Mizumura Hiroyuki   Hagino Hiroshi   Teshima Ryota  

Modern Rheumatology, Vol. 17, Iss. 3, 2007-06 ,pp. : 198-205

Springer Publishing Company

Access to resources Recommend Favorite